Log In
BCIQ
Print this Print this
 

PGN-503

  Manage Alerts
Collapse Summary General Information
Company Periphagen Inc.
DescriptionNET drug expressing Neurotrophin-3
Molecular Target Neurotrophin 3 (NTF3)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationNeuropathy
Indication DetailsTreat & prevent chemotherapy-induced peripheral neuropathy (CIPN)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today